Medicine & Health

Researchers have devised a new hearing test that measures the auditory brainstem response 20 times faster than current methodology.The marvels of mathematics may open the door to a new, improved hearing test for newborns. A mathematician and a recent electrical engineering doctoral graduate from Washington University in St. Louis have devised a hearing test that measures the auditory brainstem response 20 times faster than current methodology. The technique allows for testing on small digital machines that takes just two minutes instead of the hour current methods take, and volunteers instead of medical personnel can administer it. This bodes well for mandatory hearing testing of newborns within three years.

Red blood cells damaged by inflammation caused by food poisoning.A protein that helps keep immune system cells from mistakenly swallowing and destroying healthy cells has been linked to an inherited disorder with symptoms similar to severe food poisoning, according to researchers at the Washington University School of Medicine and the University of Newcastle in the United Kingdom. John Atkinson, M.D., the Samuel Grant Professor of Medicine at Washington University School of Medicine in St. Louis, says the results make it possible to genetically screen patients for one form of atypical hemolytic uremic syndrome (HUS), a rare but potentially life-threatening condition linked to excessive cell damage, blood clots and kidney failure. Normal HUS, often in the headlines because of food-related outbreaks, is caused by consumption of a toxic form of the bacteria E. coli.

Jeff Ojemann/University of WashingtonImproved imaging of brain’s language areas may replace more invasive pre-surgery mapping techniques, such as the electrocortical stimulation method shown here.Advances in neurosurgery have opened the operating room door for an amazing array of highly invasive forms of brain surgery, but doctors and patients still face an incredibly important decision – whether to operate when life-saving surgery could irrevocably damage a patient’s ability to speak, read or even comprehend a simple conversation. Now, researchers at Washington University in St. Louis are developing a painless, non-invasive imaging technique that surgeons here are using to better evaluate brain surgery risks and to more precisely guide operations so that damage to sensitive language areas is avoided. The breakthrough could improve odds of success in an increasingly common surgery in which damaged sections of a patient’s temporal brain lobe are removed in an effort to alleviate epileptic seizures. November is National Epilepsy Awareness Month.

November Medical science & Health Tip Sheet

November Science & Technology Tip Sheet

A major factor contributing to Americans’ increasing body sizes appears to be increasing portion sizes.Obesity puts people at risk for heart disease, diabetes, stroke, high blood pressure and cancer. It also decreases quality of life. But that’s not stopping Americans from eating and drinking more than ever before. Almost two-thirds of Americans are either overweight or obese, and a major factor contributing to increasing body sizes appears to be increasing portion sizes. Obesity researcher Samuel Klein, M.D., the Danforth Professor of Medicine and Nutritional Science at Washington University School of Medicine in St. Louis, says the obesity epidemic continues to get worse in spite of a great deal of research about the dangers of being overweight and increasing numbers of people who are trying to lose weight. Part of the problem is that many people tend to eat what is put in front of them, and serving sizes are larger than ever before.

Patients in intensive care units are kept alive with breathing machines, dialysis, tube feeding and other extraordinary measures until their bodies can begin to recover from critical illness or traumatic injury.Sepsis, sometimes called blood poisoning, is the leading cause of death among critically ill patients in the United States. For many years, scientists believed it was the result of an uncontrolled inflammatory response, but several studies that involved anti-inflammatory drugs were not successful at improving survival. Now, a research team led by Richard S. Hotchkiss, M.D., professor of anesthesiology and of medicine and associate professor of surgery and of molecular biology and pharmacology, and Irene E. Karl, Ph.D., research professor of medicine at Washington University School of Medicine in St. Louis have found that how immune cells die in sepsis might be a key to whether patients survive. When immune cells die through a process known as programmed cell death, or apoptosis, a patient’s chance of survival appears to be much lower than if cells die through a different mechanism called necrosis.

At the time of the first MRI scans, the turquoise color shows areas of the hippocampus in patients with mild Alzheimer’s disease that are shaped differently than in healthy older people. Two years later, even more changes have occurred, represented by the purple color.Even when people have no symptoms, their brains already may be dotted with the plaques and tangles that characterize Alzheimer’s disease. As treatments to halt the progress of Alzheimer’s disease appear on the horizon, scientists are looking for new ways to identify Alzheimer’s-associated changes in the brain before cognitive decline begins. By examining brain images, researchers, led by John G. Csernansky, M.D., the Gregory B. Couch Professor of Psychiatry, and Lei Wang, Ph.D., research associate in psychiatry, both at Washington University’s Silvio Conte Center for Neuroscience Research, found that the volume and shape of certain brain structures change in different patterns during Alzheimer’s disease than in healthy aging. They believe that someday using these imaging techniques may allow for earlier diagnosis of Alzheimer’s disease, preferably before the most devastating symptoms appear.

Patients treated in the GM-CSF pilot study showed a decrease in inflammation: an inflamed colon before treatment (top) and after, showing no pathologic abnormality.Researchers at Washington University School of Medicine in St. Louis continue to make progress in finding a potential treatment for Crohn’s disease, a chronic and serious inflammatory disease of the gastrointestinal tract that affects about half a million people in the United States. Later this month, the research team of Joshua Korzenik, M.D., assistant professor of medicine, and Brian Dieckgraefe, M.D., Ph.D., also an assistant professor of medicine in the division of gastroenterology, will present preliminary data from patients with moderate to severe Crohn’s disease who were treated at 33 centers around the United States. Patients who received daily injections of a drug called GM-CSF (granulocyte macrophage colony stimulating factor), which stimulates the activity of certain cells in the immune system, tended improve. And although the data have not yet been presented, the results from the placebo-controlled phase II treatment study were positive.

Photo courtesy of Vanderbilt UniversityThe “CEO” in your brain appears to be concerned more about the consequences of your actions than how hard they are to produce. That is the implication of a detailed study of the neuronal activity in a critical area of the brain, called the anterior cingulate cortex (ACC), published in the Oct. 3 issue of the journal Science. The finding is important because the ACC plays a key role in disorders such as schizophrenia and obsessive-compulsive disorder in humans, suggests Joshua Brown, study co-author and WUSTL research associate in psychology.